NEWS RELEASE
New HT-SPR Facility at the University of Oxford Featuring Carterra LSAXT
Carterra is proud to support the launch of a new high-throughput surface plasmon resonance (HT-SPR) facility within the Department of Paediatrics at the University of Oxford, featuring the Carterra LSAXT platform. Based in the Draper Lab, this facility will expand access to advanced kinetic and affinity analysis for antibody and TCR molecular characterization, strengthening Oxford’s capabilities while serving the wider UK bioscience community.
Carterra has a long and productive history of collaboration with Oxford, including co-organizing a highly successful scientific symposium that attracted strong engagement from researchers across the University and the surrounding region. Oxford scientists have also been active participants in Carterra user meetings, training events, and technical workshops—helping build a robust and growing network of experienced users.
To support the success of the new HT-SPR facility, Carterra is committed to active partnership with Oxford to drive awareness, engagement, and uptake. This includes promoting the facility through Carterra scientific symposia, user meetings, and networking events, as well as supporting Oxford-based outreach such as annual “Lunch and Learn” sessions and on-site events.
Together, these efforts will help ensure strong visibility for the facility and broaden access to high-throughput SPR workflows, enabling researchers at Oxford and beyond to accelerate discovery with confidence.
Media Contact:
Cheri Salazar
(408) 594-9400
csalazar@carterra-bio.com
About Carterra, Inc.
Carterra® is a leading provider of innovative technologies designed to accelerate the discovery of novel large and small molecule therapeutic candidates. Carterra’s high throughput screening and characterization technology combines patented microfluidics with real-time High Throughput Surface Plasmon Resonance (HT-SPR) instruments, consumables, and industry-leading Kinetic and Epitope Analysis and Visualization Software™, delivering up to 100 times the throughput in 10% of the time while using only 1% of the sample compared to existing platforms.